查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594523

非鸦片类止痛贴片市场：按贴片类型、适应症和分布划分 - 2025-2030 年全球预测

Non-opioid Pain Patches Market by Patch Type (Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches), Indication (Arthritis, Back Pain, Fibromyalgia), Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年非鸦片类止痛贴市场价值为7.0129亿美元，预计2024年将达到7.9097亿美元，复合年增长率为12.88%，到2030年将达到16.3777亿美元。

非阿片类止痛贴片市场重点在于旨在避免使用鸦片类药物并透过经皮给药或替代疗法缓解疼痛的产品。这些修补程式对于满足阿片类药物成瘾危机中对更安全的疼痛管理解决方案日益增长的需求至关重要。它可应用于从慢性疼痛管理到术后护理的各种环境，并且在医院、诊所和居家照护等最终使用环境中具有多种用途。慢性疼痛疾病的日益普及、配方技术的进步以及对非成瘾性止痛解决方案的认识不断增强，推动了市场成长。关键机会在于透过有关非阿片类药物选择的教育宣传活动扩大用户群，与医疗保健提供者合作以扩大采用范围，并利用下一代贴片技术提高药物输送效率。然而，市场面临严格的监管要求、高昂的市场开拓成本以及来自传统止痛方法的竞争等挑战。考虑到这些挑战，关键的创新领域包括开发新的贴片材料以提高黏附力和舒适度，以及探索数位健康功能的整合以实现个人化疼痛管理。为了维持和发展市场，企业应专注于建立强大的研发能力，优化供应链以降低成本，并形成策略联盟以渗透市场。预防性医疗保健和个人化医疗的趋势呈现出一条重要的成长道路，并凸显了市场教育和贴片功效实证检验的重要性。适应监管环境并适应不断变化的消费者对整体微创治疗的偏好对于保持市场竞争力至关重要。了解这些动态可以帮助公司製定有效的策略，克服成长障碍，并在不断发展的非鸦片类疼痛管理领域中抓住新机会。

主要市场统计
基准年[2023] 70129万美元
预测年份 [2024] 7.9097 亿美元
预测年份 [2030] 16.3777亿美元
复合年增长率（%） 12.88%

市场动态：快速发展的非阿片类止痛贴片市场的关键市场洞察

非阿片类止痛贴片市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性和急性疼痛相关疾病的增加
    • 医疗保健专业人员越来越偏好非鸦片类药物贴剂
    • 非鸦片类止痛贴片相对于传统药物的优势
  • 市场限制因素
    • 对非鸦片类止痛贴片缺乏认识
  • 市场机会
    • 政府对非成瘾性疼痛治疗​​解决方案的有利倡议
    • 活性化疼痛管理治疗的研究和开发
  • 市场挑战
    • 严重的副作用和替代治疗的可用性

波特的五力：驾驭非鸦片类止痛贴片市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解非鸦片类止痛贴片市场的外部影响

外部宏观环境因素在塑造非鸦片类止痛贴市场的表现动态中发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解非鸦片类止痛贴片市场的竞争格局

非阿片类止痛贴市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵非鸦片类止痛贴片市场供应商的绩效评估

FPNV定位矩阵是评估非鸦片类止痛贴片市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划非鸦片类止痛贴片市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，非阿片类止痛贴市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性和急性疼痛相关疾病的增加
      • 医护人员对非鸦片类药物贴片的兴趣日益浓厚
      • 非鸦片类止痛贴与传统药物相比的优势
    • 抑制因素
      • 与非鸦片类止痛贴相关的认知限制
    • 机会
      • 政府优先采取非成瘾性疼痛治疗​​解决方案
      • 增加疼痛管理治疗的研究和开发
    • 任务
      • 严重的副作用和替代治疗方法的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章非鸦片类止痛贴片市场（以贴片类型）

  • 辣椒素贴片
  • 双氯芬酸钠贴剂
  • 酮洛芬贴剂
  • Lidocaine贴剂
  • 水杨酸甲酯贴片

第七章非鸦片类止痛贴片市场（依适应症）

  • 关节炎
  • 腰痛
  • 纤维肌痛
  • 偏头痛和头痛
  • 肌肉拉伤和扭伤
  • 带状疱疹后遗症神经痛

第八章 非鸦片类止痛贴片市场经销商

  • 药局
  • 医院
  • 网路药房

第九章美洲非鸦片类止痛贴片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太非鸦片类止痛贴片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲非鸦片类止痛贴片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bridges Consumer Healthcare, LLC
  • Cardinal Health, Inc.
  • Endo International plc
  • GlaxoSmithKline Plc.
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • SCILEX Pharmaceuticals Inc.
  • Sorrento Therapeutics, Inc.
  • Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • Teikoku Seiyaku Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Veridian Healthcare
  • Virpax Pharmaceuticals, Inc.
Product Code: MRR-AD36CD897D7B

The Non-opioid Pain Patches Market was valued at USD 701.29 million in 2023, expected to reach USD 790.97 million in 2024, and is projected to grow at a CAGR of 12.88%, to USD 1,637.77 million by 2030.

The non-opioid pain patch market focuses on products designed to alleviate pain through transdermal delivery of medications and alternative therapies, avoiding the use of opioids. These patches are crucial for addressing the growing demand for safer pain management solutions amid opioid addiction crises. They find applications in various settings, from chronic pain management to post-operative care, making them versatile in end-use environments such as hospitals, clinics, and home care. Market growth is propelled by an increasing prevalence of chronic pain disorders, advancements in formulation technologies, and heightened awareness of non-addictive pain relief solutions. Key opportunities lie in expanding the user base through awareness campaigns about non-opioid options, partnerships with healthcare providers for wider adoption, and leveraging technology for next-generation patches that enhance drug delivery efficiency. However, the market faces challenges such as stringent regulatory requirements, high development costs, and competition from traditional pain relief methods. Amid these challenges, crucial innovation areas include developing novel patch materials that improve adhesion and comfort, as well as exploring the integration of digital health features for personalized pain management. For market sustenance and growth, companies should focus on building strong R&D capabilities, optimizing supply chains to reduce costs, and engaging in strategic collaborations for market penetration. Transitioning trends towards preventive healthcare and personalized medicine present significant growth avenues, highlighting the importance of market education and evidence-based validation of patch efficacy. It's essential that market players navigate regulatory landscapes adeptly and adapt to evolving consumer preferences for holistic and minimally invasive treatments to sustain competitiveness. Deciphering these dynamics will enable companies to strategize effectively, overcoming growth barriers and capturing emerging opportunities in the evolving non-opioid pain management sector.

KEY MARKET STATISTICS
Base Year [2023] USD 701.29 million
Estimated Year [2024] USD 790.97 million
Forecast Year [2030] USD 1,637.77 million
CAGR (%) 12.88%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-opioid Pain Patches Market

The Non-opioid Pain Patches Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Chronic and Acute Pain-Related Disorders
    • Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
    • Benefits Associated with Non-opioid Pain Patches over Conventional Medications
  • Market Restraints
    • Limited Awareness Associated with Non-opioid Pain Patches
  • Market Opportunities
    • Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
    • Rising R&D in Pain Management Treatments
  • Market Challenges
    • Significant Side Effect Coupled with Availability of Alternative Treatments

Porter's Five Forces: A Strategic Tool for Navigating the Non-opioid Pain Patches Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-opioid Pain Patches Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-opioid Pain Patches Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-opioid Pain Patches Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-opioid Pain Patches Market

A detailed market share analysis in the Non-opioid Pain Patches Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-opioid Pain Patches Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-opioid Pain Patches Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-opioid Pain Patches Market

A strategic analysis of the Non-opioid Pain Patches Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Non-opioid Pain Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Patch Type, market is studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches.
  • Based on Indication, market is studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-Herpetic Neuralgia.
  • Based on Distribution, market is studied across Drug Stores, Hospitals, and Online Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Chronic and Acute Pain-Related Disorders
      • 5.1.1.2. Growing Inclination of Healthcare Professionals towards Non-Opioid Patches
      • 5.1.1.3. Benefits Associated with Non-opioid Pain Patches over Conventional Medications
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Awareness Associated with Non-opioid Pain Patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable Government Initiatives towards Non-Addictive Pain Therapeutic Solutions
      • 5.1.3.2. Rising R&D in Pain Management Treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Significant Side Effect Coupled with Availability of Alternative Treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Non-opioid Pain Patches Market, by Patch Type

  • 6.1. Introduction
  • 6.2. Capsaicin Patches
  • 6.3. Diclofenac Patches
  • 6.4. Ketoprofen Patches
  • 6.5. Lidocaine Patches
  • 6.6. Methyl Salicylate Patches

7. Non-opioid Pain Patches Market, by Indication

  • 7.1. Introduction
  • 7.2. Arthritis
  • 7.3. Back Pain
  • 7.4. Fibromyalgia
  • 7.5. Migraines & Headaches
  • 7.6. Muscle Strain & Sprains
  • 7.7. Post-Herpetic Neuralgia

8. Non-opioid Pain Patches Market, by Distribution

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospitals
  • 8.4. Online Pharmacies

9. Americas Non-opioid Pain Patches Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Non-opioid Pain Patches Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Non-opioid Pain Patches Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bridges Consumer Healthcare, LLC
  • 2. Cardinal Health, Inc.
  • 3. Endo International plc
  • 4. GlaxoSmithKline Plc.
  • 5. Hisamitsu Pharmaceutical Co., Inc.
  • 6. Johnson & Johnson Services, Inc.
  • 7. Pfizer Inc.
  • 8. Sanofi S.A.
  • 9. SCILEX Pharmaceuticals Inc.
  • 10. Sorrento Therapeutics, Inc.
  • 11. Teh Seng Pharmaceutical Mfg. Co., Ltd.
  • 12. Teikoku Seiyaku Co. Ltd.
  • 13. Teva Pharmaceutical Industries Ltd.
  • 14. Veridian Healthcare
  • 15. Virpax Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. NON-OPIOID PAIN PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. NON-OPIOID PAIN PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NON-OPIOID PAIN PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NON-OPIOID PAIN PATCHES MARKET DYNAMICS
  • TABLE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CAPSAICIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DICLOFENAC PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY KETOPROFEN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY LIDOCAINE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY METHYL SALICYLATE PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY FIBROMYALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MIGRAINES & HEADACHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY MUSCLE STRAIN & SPRAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY POST-HERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2023